A practical checklist for evaluating decentralized trial technology vendors, built from an RF engineer’s view of where data quality actually breaks.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Fighting COVID-19 Like A Pro
Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).
-
Managing Medical Coding Dictionary Updates In Clinical Trials
Dictionary updates can impact data consistency, safety monitoring, and reporting. Learn key considerations for managing coding version changes while maintaining data integrity.
-
Enhancing Participant Payments: A New Approach
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
Bespoke RTSM Systems Empower Precision Medicine
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
Taming The Complex Clinical-Trial Ecosystem
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
Managing Drug And Data Requirements In Decentralized Clinical Trials
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Demystifying AI In Clinical Trials
AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
-
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC
Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.
RECENT NEWSLETTERS
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech